ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 56 filers reported holding ODONATE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $160,000 | +213.7% | 118,871 | +568.9% | 0.00% | – |
| Q3 2021 | $51,000 | +15.9% | 17,771 | +42.1% | 0.00% | – |
| Q2 2021 | $44,000 | -29.0% | 12,507 | -31.0% | 0.00% | – |
| Q1 2021 | $62,000 | -46.1% | 18,138 | +203.7% | 0.00% | – |
| Q4 2020 | $115,000 | +62.0% | 5,972 | +11.8% | 0.00% | – |
| Q3 2020 | $71,000 | -93.8% | 5,341 | -80.1% | 0.00% | – |
| Q2 2020 | $1,138,000 | +54.4% | 26,867 | +0.5% | 0.00% | – |
| Q1 2020 | $737,000 | -14.6% | 26,735 | +0.6% | 0.00% | – |
| Q4 2019 | $863,000 | -0.5% | 26,580 | -20.1% | 0.00% | – |
| Q3 2019 | $867,000 | +230.9% | 33,270 | +366.9% | 0.00% | – |
| Q2 2019 | $262,000 | +244.7% | 7,126 | +109.6% | 0.00% | – |
| Q1 2019 | $76,000 | -7.3% | 3,400 | -42.3% | 0.00% | – |
| Q4 2018 | $82,000 | +156.2% | 5,892 | +251.6% | 0.00% | – |
| Q3 2018 | $32,000 | +39.1% | 1,676 | +58.4% | 0.00% | – |
| Q2 2018 | $23,000 | +76.9% | 1,058 | +79.3% | 0.00% | – |
| Q1 2018 | $13,000 | – | 590 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 4,207,086 | $5,553,000 | 0.28% |
| Samsara BioCapital, LLC | 700,421 | $925,000 | 0.23% |
| Hennion & Walsh Asset Management, Inc. | 69,264 | $91,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 384,995 | $506,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 43,752 | $58,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,000 | $2,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 47 | $0 | 0.00% |
| BESSEMER GROUP INC | 230 | $0 | 0.00% |